Release Date: 07/02/22 12:56 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 191.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%